-
EP3541375
European procedure
Extract from the Register of European Patents
EP Citations: EP3541375
| Cited in | Search | Type: | Patent literature | Publication No.: | WO9857960
[A] (SCHERING CORP [US], et al) [A] 1-11* page 4, line 5 - page 4, line 13; claim -; compound 246 *; | Type: | Patent literature | Publication No.: | WO2006113376
[A] (NOVARTIS AG [CH], et al) [A] 1-11 * paragraph [0001]; compounds 65,70,73,82,88 *; | Type: | Patent literature | Publication No.: | WO2008016676
[X] (CYTOKINETICS INC [US], et al) [X] 1 * page 75, 1st compound; paragraph [0002] * | Cited in | International search | Type: | Patent literature | Publication No.: | US2008003214
[A] (CEZANNE BERTRAM [DE], et al) [A] 1-6, 8-16 * entire document *; | Type: | Patent literature | Publication No.: | US2008287453
[A] (BOWER JUSTIN FAIRFIELD [GB], et al) [A] 1-6, 8-16 * entire document' *; | Type: | Patent literature | Publication No.: | US2011033459
[A] (CONLEY PAMELA B [US], et al) [A] 1-6, 8-16* entire document * | Cited in | by applicant | Type: | Patent literature | Publication No.: | US2008003214
| Type: | Patent literature | Publication No.: | US2011033459
| Type: | Non-patent literature | Publication information: | - SHARIAT-MADAR et al., Blood, (20060000), vol. 108, pages 192 - 199 | Type: | Non-patent literature | Publication information: | - "Contact ActivationPathway", COLEMAN, R., Hemostasis and Thrombosis, Lippincott Williams & Wilkins, (20010000), pages 103 - 122 | Type: | Non-patent literature | Publication information: | - SCHMAIER, A.H., "Contact Activation", Thrombosis and Hemorrhage, (19980000), pages 105 - 128 | Type: | Non-patent literature | Publication information: | - RENNE et al., J Exp. Med., (20050000), vol. 202, pages 271 - 281 | Type: | Non-patent literature | Publication information: | - KLEINSCHMITZ et al., J Exp. Med., (20060000), vol. 203, pages 513 - 518 | Type: | Non-patent literature | Publication information: | - KENNE, E.RENNE, T., "Factor XII: a drug target for safe interference with thrombosis and inflammation", Drug DISCOvery Today, (20140000), vol. 19, pages 1459 - 146 | Type: | Non-patent literature | Publication information: | - RENNE, T. et al., "In vivo roles of factor XII", Blood, (20120000), vol. 120, doi:10.1182/blood-2012-, pages 4296 - 4303, XP055599576 | DOI: | http://dx.doi.org/10.1182/blood-2012- | Type: | Non-patent literature | Publication information: | - KLEINSCHNITZ, C. et al., "Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis", Journal of Experimental Medicine, (20060000), vol. 203, doi:10.1084/jem.20052458, pages 513 - 518, XP055110912 | DOI: | http://dx.doi.org/10.1084/jem.20052458 | Type: | Non-patent literature | Publication information: | - GRUBER, A. et al., Therapeutic antibodies against factor XII, Vanderbilt University, (20140000), page 91 | Type: | Non-patent literature | Publication information: | - WORM, M. et al., "The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti inflammatory activities", Annals of Translational Medicine, (20150000), vol. 3, pages 241 - 245 | Type: | Non-patent literature | Publication information: | - CHENG, Q.TUCKER, E. I.PINE, M. S.SISLER, I.MATAFONOV, A.SUN, M.-F.WHITE-ADAMS, T. C.SMITH, S. A.HANSON, S. R.MCCARTY, O. J. T., "A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo", Blood, (20100000), vol. 116, doi:10.1182/blood-2010-02-270918, pages 3981 - 3989, XP055355312 | DOI: | http://dx.doi.org/10.1182/blood-2010-02-270918 | Type: | Non-patent literature | Publication information: | - GAILANI, D. et al., "Factor XI and contact activation as targets for antithrombotic therapy", Journal of Thrombosis andHaemostasis, (20150000), vol. 13, pages 1383 - 1395 | Type: | Non-patent literature | Publication information: | - CHOUTALALAY, Adv. Enzyme Regul., (19840000), vol. 22, pages 27 - 55 |